Navigation Links
Dr. Ross Rich of Cave Creek Equine Recently Presented the Outcome of 42 Horses with Stifle Injuries Treated with Vet-Stem Regenerative Cell Therapy
Date:11/27/2013

Poway, California (PRWEB) November 27, 2013

Dr. Ross Rich of Cave Creek Equine Surgical and Diagnostic Imaging Center in Arizona had the opportunity to present his positive findings on the "Outcome of 42 Horses with Stifle Injuries Treated with Adipose-Derived Regenerative Cells (stem cells) and IRAP" (Interleukin-1 Receptor Antagonist Protein Therapy) at this year’s North American Veterinary Regenerative Medicine Association Conference in Atlanta Georgia this month.

Dr. Rich’s findings proved his hypothesis true that treatment of stifle injuries with stem cells and IRAP could improve athletic outcomes, performance longevity, and shorten recovery times when compared to other treatment methods for similar injuries. Stifle injuries causing ongoing lameness are relatively common in performance horses and have prematurely ended many an equine athlete’s career. Stifle problems can be refractory to treatment and have long recovery times. Previous studies evaluating treatment of stifle abnormalities with stem cells had low case numbers and limited athletic performance follow-up, but Dr. Rich’s presentation shed some new light on the topic.

This study focused on a large series of clinical cases, with a standardized rehabilitation program, and a stringent, long-term criterion for success. Dr. Rich’s findings demonstrated good to excellent (over 64% of the subjects) long-term return to full work, in horses with lameness caused by stifle injuries, treated with arthroscopy, stem cell therapy by Vet-Stem, and IRAP. Dr. Rich also found evidence in this study to support the continued use of these treatment methods for successful treatment of bone, cartilage, and ligament injuries/lesions of the equine stifle.

Dr. Rich approaches his care of horses with a holistic methodology believing that lameness can be a result of more than one injury. His facility in Cave Creek offers medical and surgical services geared towards diagnosis and treatment of sports-related problems in the elite and future equine athlete. Cave Creek Equine Surgical & Diagnostic Imaging Center strives to keep the veterinarians, technicians, and office staff updated in the most innovative care of the horse from the beloved pet to international competition horse, and have treated over 600 horses with Vet-Stem’s Regenerative Cell Therapy, with amazing results over the last ten years.    

About Vet-Stem, Inc.

Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11374662.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Ross Rich of Cave Creek Equine to Present at North American Veterinary Regenerative Medicine Association Conference
2. Star Scientific and Rock Creek Pharmaceuticals Announce the Publication of a Peer-Reviewed Article about the ASAP Clinical Trial Showing Immune System Support in Hashimotos Thyroiditis
3. All New Laguna Beach Meeting Packaging at the Aliso Creek Inn & Golf Course Promises to Take the Hassle Out of Planning the Company's Next Business Meeting
4. Recently Patented Technology Poised To Disrupt The Plasma Biopharmaceutical Market
5. The Alliance for the Advancement of Adult Stem Cell Therapy and Research Recently Has Proven Stem Cells To Be Effective in Dilated Cardiomyopathy
6. SoundConnect Recently Selected by iCIMS, Inc.
7. Recently FDA-Approved Full Neck Treatment for Sagging Skin Now Available at Maryland Laser Skin and Vein Institute
8. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
9. 2013 Top MLM Leader Awards Presented by ASEA, LLC
10. First Annual Michael SanInocencio Lennox-Gastaut Syndrome Research Award Presented at Annual Meeting of the Child Neurology Society
11. Successful Pediatric Studies: Key Study Design and Operational Considerations, a New Webinar Presented by Premier Research and Xtalks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):